Geron (GERN +3.3%) shoots higher after landing patent approval for a treatment method for...

|About: Geron Corporation (GERN)|By:, SA News Editor

Geron (GERN +3.3%) shoots higher after landing patent approval for a treatment method for central nervous system-related tumors.